NAD is biosynthesized from tryptophan. Therefore, experimental studies including tryptophan metabolism studies could provide insight into niacin nutrition in pregnancy. Our aim was to determine the change in niacin metabolism during pregnancy by a systemic investigation of how pregnancy alters the tryptophan-niacin metabolism in Japanese women and rats. For the human study, spot urine samples were collected from a total of 434 pregnant Japanese women who were at 5-40 wk of gestation, 50 women at 4 6 wk postpartum, and 10 nonpregnant women as the controls. For the animal study, preg nant rats were fed with a niacin-free diet, and daily urine samples were collected from day 6 of gestation to day 6 postpartum. The intermediates and metabolites of the tryptophan-nia cin pathway in the urine samples were measured. The urinary excretions of niacin metabo lites in humans and rats increased from mid pregnancy in a time-dependent manner, reached a peak of 2-3-fold during late pregnancy, and declined to control levels after child birth.
tophan-niacin pathway are soon excreted to the urine, and the amount of these substances reflects the changes in the activities of pathway enzymes. There fore, measuring these substances in the urine can eluci date the tryptophan-niacin metabolism, and we have reported the effects of numerous factors on the tryp tophan-niacin metabolism (2-4, 6, 8, 9, 12, 13). To determine how pregnancy alters the tryptophan-niacin metabolism, we investigated the urinary excretions of metabolites on the tryptophan-niacin pathway from spot urine samples in Japanese pregnant women. To confirm the change of tryptophan-niacin metabolism as a result of pregnancy, we assessed the daily urinary excretions of intermediates and metabolites on the tryp tophan-niacin pathway in pregnant rats.
SUBJECTS AND METHODS
Subjects, We recruited volunteers for this study at our obstetrical clinic at Jin-no Ladies Clinic at Hikone, Japan, and selected a total of 434 pregnant women who were at 5-40 wk of gestation, 50 women at 4-6 wk postpartum, and 10 non-pregnant women as the con trols. All subjects were non-smokers, Japanese, from the middle-upper socioeconomic class, and residing in the town of Hikone or surrounding areas. All were judged to be healthy through medical history screening and urinalysis. We guided them to take some defined life style including diet, and no intake of drugs nor vitamin supplements for at least 7 d prior to urine sampling. three compounds are excreted as Nam metabolites into the urine in humans. To assess the changes in niacin metabolism, the sum of MNA, 2-Py and 4-Py was calcu lated. This sum gradually increased from about week 20, reaching a peak of 2.3-fold at week 33, and declin ing to control levels postpartum (Fig, 4) . Rats Changes in the urinary excretion of upper metabolites on the tryptophan-niacin pathway in rats. The urinary out puts of AnA, KA, XA and 3-HA are expressed as nmol/ day, since the exact tryptophan-niacin metabolism can be assessed using daily urine samples. The AnA output to the urine did not change during pregnancy (Fig. 5A) , a similar result to that found in humans. KA, XA and 3 HA gradually increased from day 11 or 12 of gestation (mid pregnancy) and reached peaks of 2-fold at day 13 or 14 (Figs. 5P, 5C and 5D ). These excretions declined to control levels postpartum.
Changes in the urinary excretion of lower metabolites on the tryptophan-niacin pathway in rats, The urinary out puts of OA, Nam, MNA, 2-Py, and 4-Py are also expressed as nmol/d. QA increased from day 12 of ges tation to day 18, Nam increased at day 14 and 15, MNA increased from day 16 of gestation to day 3 post partum, and 2-Py and 4-Py increased from day 13 of gestation to day 21 or 19, respectively (Fig. 6) . The peak in increasing OA was on day 13 of gestation with a 2.3 fold increase, MNA peaked at day 21 of gestation and day 1 postpartum with an 8.4-fold increase, 2-Py was at day 14 with a 3.0-fold increase, and 4-Py was on day 15 with a 2.6 fold increase.
The sum of Nam, MNA, 2-Py and 4-Py was calcu lated, since these are all excreted as Nam metabolites into urine in rats. This sum gradually increased from day 13 of gestation to day 1 postpartum, reaching a peak of a 2.7-fold increase on day 16, and decreasing to control levels from day 2 postpartum (Fig, 7) .
Changes in the conversion ratio of tryptophan-niacin in rats. The conversion ratio of tryptophan-niacin was significantly changed with pregnancy as shown in Fig.  8 .
Correlations of the urinary excretion of nicotinarnide metabolites with the intermediates in the tryptophan-niacin pathway in rats. To elucidate the change in the tryp tophan-niacin metabolism during pregnancy, correla tions of the urinary excretion of the sum of Nam, MNA, 2-Py and 4-Py with 3-HA or OA, the intermediates in the tryptophan-niacin pathway in rats were calculated. During the whole of the period analyzed from day 6 of gestation to day 6 postpartum, the sum was signifi cantly correlated with 3-A and QA (correlation (r)=0337; p<0.0001 and r=0.614; p<0.001, respec tively). The data were divided into three periods; mid pregnancy ranged from day 6 of gestation to day 15, late pregnancy from day 16 to 21, and postpartum from day 1 to 6 postpartum. 3-HA was significantly correlated with the sum in mid pregnancy (r=0.633, p<0.0001) but not in late pregnancy (r=0.015, p=0.916) nor postpartum (r=0.093, p=0.505), OA was significantly correlated with the sum in all three periods, mid pregnancy (r=0.675, p<0.0001), late pregnancy (r=0.613, p<0,0001) and postpartum (r=0,511, p<o.0001).
DISCUSSION
There is a report that the deaths by pellagra in women was approximately 2-fold excess those in men (22 The expression of IDO is ubiquitous in many tissues , and its expression level is higher in the placenta, intes tine and lung (23, 26) . Placental IDO activity and mRNA expression are positively regulated by cytokines such as interferon-y (27). Munn et al, showed that the administration of 1-methyltryptophan, an inhibitor of IDO, to pregnant mice induced a rapid abortion of allo geneic concepti due to T-cells (28) . They propose a role of IDO in the placenta during pregnancy in suppressing the fetal alloantigen-induced activation of maternal T cells, preventing them from elaborating further immune responses, which are lethal to the developing fetus (29) . Plasma tryptophan concentration decreases during pregnancy in women, and plasma concentra tions of immune activation markers neopterin and 55 kD soluble tumor necrosis factor receptor (sTNF R55) are inversely correlated to the plasma tryptophan, suggesting an involvement of IDO activation in tryp tophan degradation during pregnancy (30) . A high tryptophan-degrading activity is detected in early con cepti in mice, whereas IDO protein and its mRNA are not expressed during early gestation but appear 2-3 d later to the peak of activity (24) . The early tryptophan degrading activity in murine concepti is due to the gene expression of TDO (24) . These findings cannot deter mine whether the enhancement of the tryptophan-nia cin metabolism from mid pregnancy to delivery is due to the increase in IDO activity in the placenta or not. TDO is specifically expressed in the liver (31) , and the liver TDO activity in pregnant rats increases from the 12th day of pregnancy to the 20th day relative to non pregnant rats (32) . Although the precise reason for this enhancement of tryptophan degradation in the tryp tophan-niacin metabolism is unclear, it is plausible that it results from changes in activity of IDO or TDO.
In conclusion, acceleration in urinary excretions of niacin metabolites occurs both in Japanese women and in rats during pregnancy. Changed urinary excretions of niacin metabolites reflect mainly the increased tryp tophan-niacin metabolism, and are parallel with those of 3-HA in mid pregnancy and with OA throughout pregnancy. We conclude that the changes in the uri nary excretion of the metabolites of the tryptophan-nia cin pathway is due to changes in the IDO and/or TDO and ACMSD activities during pregnancy.
